EXPERIENCE OF PHARMACOGENETIC TESTING IN THE TREATMENT OF ANTIPSYCHOTICS

被引:0
|
作者
Kaydan, M. [1 ]
Zakharova, N. [1 ]
机构
[1] Dept Hlth Moscow, Psychiat Hosp 1, Moscow, Russia
关键词
D O I
10.1192/j.eurpsy.2023.2272
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
EPV0978
引用
收藏
页码:S1070 / S1070
页数:1
相关论文
共 50 条
  • [41] New Hope for Pharmacogenetic Testing
    Nurnberger, John I., Jr.
    AMERICAN JOURNAL OF PSYCHIATRY, 2009, 166 (06): : 635 - 638
  • [42] The relevance of pharmacogenetic testing in forensics
    Weiss, Helmar
    Vasiliauskas, Erikas
    Blendl, Volkmar
    Maksimiuk, Aleh
    NERVENARZT, 2024,
  • [43] FDA perspectives on pharmacogenetic testing
    Harper, CC
    Philip, R
    Robinowitz, M
    Gutman, SI
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2005, 5 (05) : 643 - 648
  • [44] Consent and privacy in pharmacogenetic testing
    John A. Robertson
    Nature Genetics, 2001, 28 : 207 - 209
  • [45] Adolescent perceptions of pharmacogenetic testing
    Stancil, Stephani L.
    Berrios, Courtney
    Abdel-Rahman, Susan
    PHARMACOGENOMICS, 2021, 22 (06) : 335 - 343
  • [46] Considerations of pharmacogenetic testing in children
    Haga, Susanne B.
    Solomon, Benjamin D.
    PHARMACOGENOMICS, 2016, 17 (09) : 975 - 977
  • [47] Pharmacogenetic Testing for Warfarin Sensitivity
    Lyon, Elaine
    McMillin, Gwen
    Melis, Roberta
    CLINICS IN LABORATORY MEDICINE, 2008, 28 (04) : 525 - 537
  • [48] Using Pharmacogenetic Testing to Tailor Warfarin Therapy: The Singapore Experience and What the Future Holds
    Chang, Grace Shu-wen
    Tan, Doreen Su-Yin
    EUROPEAN CARDIOLOGY REVIEW, 2020, 15
  • [49] Pharmacogenetic testing in primary care
    Parve, Julie
    Carlile, Jennifer
    Parve, Josiah
    NURSE PRACTITIONER, 2019, 44 (10): : 44 - 49
  • [50] Consent and privacy in pharmacogenetic testing
    Robertson, JA
    NATURE GENETICS, 2001, 28 (03) : 207 - 209